
RepliCel Life Sciences Continues Restructuring With Share Structure Consolidation
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/22/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF)(TSX VENTURE: RP) (FRANKFURT: P6P1), a clinical stage regenerative medicine company focused on the …